StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

STLN — Starling Oncology, Inc.

FAIR (MOS +24.3%) · Quality 55/100

Value Score 30 days ago: 5.8 → today 41.8

Price
4.2
Intrinsic value
5.55
Margin of safety
+24.3%
Implied growth (reverse DCF)
+3.0%
model assumes +10.0%
Value Score
41.8
Quality
55
Psychology
40.4
Discovery
55.4
price/volume attention only
Moat score
21
erosion: none

Value Score: top 8% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for STLN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/STLN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is STLN undervalued?

As of 2026-11-11, STLN trades at 4.2 against a computed intrinsic value of 5.55 (+24.3% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Starling Oncology, Inc.'s Value Score?

Starling Oncology, Inc.'s Value Score is 41.8 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.